GLRA
ELV icon

Gerald L. Ray & Associates’s Elevance Health ELV Stock Holding History

Gerald L. Ray & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$720K Sell
3,790
-103
-3% -$19.6K 0.09% 188
2017
Q2 		$732K Sell
3,893
-25
-0.6% -$4.49K 0.09% 185
2017
Q1 		$648K Hold
3,918
– – 0.09% 195
2016
Q4 		$563K Sell
3,918
-754
-16% -$101K 0.08% 202
2016
Q3 		$585K Sell
4,672
-1,000
-18% -$129K 0.09% 189
2016
Q2 		$745K Hold
5,672
– – 0.12% 156
2016
Q1 		$788K Hold
5,672
– – 0.13% 143
2015
Q4 		$790K Sell
5,672
-35
-0.6% -$4.82K 0.12% 144
2015
Q3 		$799K Buy
5,707
+754
+15% +$113K 0.13% 138
2015
Q2 		$813K Hold
4,953
– – 0.12% 152
2015
Q1 		$764K Hold
4,953
– – 0.12% 164
2014
Q4 		$623K Hold
4,953
– – 0.1% 177
2014
Q3 		$593K Hold
4,953
– – 0.1% 176
2014
Q2 		$533K Sell
4,953
-100
-2% -$10.3K 0.09% 184
2014
Q1 		$503K Hold
5,053
– – 0.09% 179
2013
Q4 		$466K Sell
5,053
-100
-2% -$8.88K 0.09% 183
2013
Q3 		$431K Hold
5,153
– – 0.09% 179
2013
Q2 		$422K Buy
+5,153
New +$386K 0.09% 173

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Gerald L. Ray & Associates's ELV Position: Q3 2017 in Review

Gerald L. Ray & Associates reduced its Elevance Health (ELV) stake by 2.6% in Q3 2017, selling an estimated $19.6K and leaving 3,790 shares worth $720K. The position accounts for 0.09% of the portfolio, ranked #188.

Gerald L. Ray & Associates first reported a position in ELV in Q2 2013 and has held it in 18 quarters since. The position peaked at $813K in Q2 2015. 844 funds tracked by Wall St. Rank hold ELV as of Q3 2017.

  • Gerald L. Ray & Associates held 3,790 shares of Elevance Health worth $720K as of Q3 2017.
  • Gerald L. Ray & Associates sold 103 Elevance Health shares in Q3 2017, an estimated $19.6K.
  • Elevance Health made up 0.09% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #188 holding.
  • Gerald L. Ray & Associates first reported a position in Elevance Health in Q2 2013 and has held it in 18 quarters since.
  • Gerald L. Ray & Associates's Elevance Health position peaked at $813K in Q2 2015.
  • 844 funds tracked by Wall St. Rank held Elevance Health as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.